Ohio residents who were injured by Invokana (canagliflozin) or other similar Type-2 Diabetes medicines may be eligible to file an Ohio Invokana lawsuit. The Kollin Firm is currently evaluating claims by patients who were diagnosed with ketoacidosis-also known as acidosis or diabetic ketoacidosis (DKA)-after taking one of the following Type-2 Diabetes medicines:
- Invokana (generic: canagliflozin)
- Invokamet (generic: canagliflozin/metformin)
- Jardiance (generic: empagliflozin)
- Xigduo XR (generic: dapagliflozin/metformin)
- Farxiga (generic: dapagliflozin)
- Glyzambi (generic: empagliflozin/linagliptin)
In May 2015, the FDA warned that treatments with these drugs may put patients at risk for a potentially life-threatening health condition known as ketoacidosis. We are concerned that the pharmaceutical companies that manufacture the above medicines may be responsible for selling a defective drug without properly warning about its risks.
Free Ohio Invokana Lawsuit Evaluation: If you or your loved one is a resident of Ohio who was injured by Invokana or other similar Type-2 Diabetes medications, please contact our law firm immediately for a free case consultation. If you file a lawsuit, you could receive compensation for your injury, medical expenses, and more.
What is Invokana?
Invokana (generic: canagliflozin) is an oral medications approved by the FDA for the treatment of Type-2 Diabetes. Invokana and similar medicines belong to a class of medications known as sodium glucose cotransporter-2 (SGLT2) inhibitors, which have been shown to lower blood sugar in adults with Type-2 Diabetes.
What is Ketoacidosis?
Also known as acidosis or diabetic ketoacidosis (DKA), ketoacidosis is a condition that causes the body to produce excess levels of blood acids, or ketones, which can lead to a host of medical complications, including organ failure, diabetic coma, and even death.
Food and Drug Administration’s Investigation of Invokana
In May 2015, the FDA released a drug safety announcement stating that it was investigating reports that certain Type-2 Diabetes medications caused a serious medical condition known as ketoacidosis. This investigation was launched after the FDA had reviewed multiple adverse event reports from patents who were seriously injured or hospitalized due to ketoacidosis after taking Type-2 Diabetes medications, including Invokana.
In the FDA’s announcement, the agency warned patients that they should seek immediate medical attention if they experience any symptoms of ketoacidosis, including:
- Difficulty Breathing
- Unusual Fatigue or Sleepiness
- Unexplained Abdominal Pain
Invokana has also been linked to reports of:
- Kidney Failure
- Excessive Weight Loss
- Heart Attack
Do I have an Invokana Case?
The Product Liability & Defective Drug Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Invokana lawsuits. We are handling individual litigation nationwide and currently accepting new cases in Ohio.
If you or a loved one were diagnosed with ketoacidosis after being treated with Invokana or another of the SGLT2 inhibitor class of medications, you should contact our law firm immediately. You may be entitled to compensation by filing an Ohio Invokana lawsuit, and we can help.